david_webb_mhra

MHRA appoints three directors to its Board

pharmafile | July 31, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, MHRA 

The Department of Health has announced that three new non-executive directors are joining the Medicines and Healthcare Products Regulatory Agency.

The three directors joining the MHRA are: Dame Valerie Beral, director of the Cancer Epidemiology Unit at the University of Oxford; Professor Alexander Markham, Professor of Medicine at the University of Leeds; and Professor David Webb (pictured), Christison Professor of Therapeutics and Clinical Pharmacology at the University of Edinburgh.

MHRA incorporates the Clinical Practice Research Datalink (CPRD), an e-health research service and the National Institute for Biological Standards and Control (NISBC), which assures the standards of biological medicines.

Advertisement

Lord Howe, health minister, said: “I am pleased to appoint Dame Valerie Beral, Professor Alexander Markham and Professor David Webb as non-executive directors of the MHRA. They bring a wealth of experience to our board and will play a key role in the leadership of the agency in its vital role, improving and protecting public health.”

Related Content

IMed Consultancy releases white paper on Digital Mental Health Technologies

IMed Consultancy, a consultancy and service provider for the medical and health technology sector, has …

Dual immunotherapy for bowel cancer now available under NHS

Dual immunotherapy, a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), has been granted extension in …

MHRA approve new treatment combo for transplant-ineligible multiple myeloma patients

The Medicine and Healthcare products Regulatory Agency (MHRA) has approved quadruplet therapy, SARCLISA (isatuximab) in …

The Gateway to Local Adoption Series

Latest content